Bone Marrow Transplantation News

Patients who underwent allogeneic transplantation demonstrated significantly higher risk for cognitive impairment after transplant than healthy controls, according to results from a prospective, longitudinal study.

Patients with high-risk follicular lymphoma demonstrated low nonrelapse mortality and promising OS rates after hematopoietic stem cell transplantation, according to published findings.

Click here to read the Cover Story, “Deeper understanding of disease biology may improve outcomes in triple-negative breast cancer.”

Home-based care is the most traditional form of health care.

Following a hematopoietic stem cell transplant, a novel imaging test using 18F-fluorothymidine identified success of engraftments weeks before a traditional blood test, according to study results.

Hypomethylating agents azacitidine and decitabine appeared associated with a 5-year OS probability rate of 4% among patients with myelodysplastic syndrome with refractory anemia with excess blasts who did not undergo allogeneic stem cell transplantation, according to a study published in Blood.

Cytomegalovirus infection occurs among approximately 40% of cytomegalovirus-seropositive patients within the first 100 days following hematopoietic stem cell transplant and is associated with high morbidity and high mortality among HSCT recipients.

Alexis A. Thompson, MD, MPH, took over as ASH president in January.

SALT LAKE CITY — Diversity of gut microbiota at the time of neutrophil engraftment in allogeneic hematopoietic stem cell transplantation appeared associated with OS, according to results of an international multicenter cohort study presented at BMT Tandem Meetings.

The addition of abatacept to standard therapy reduced the incidence of severe acute graft-versus-host disease to less than 5%, according to phase 2 study results presented at ASH Annual Meeting and Exposition.